Coherus Biosciences is a leading biosimilar company that develops and commercializes high-quality therapeutics for major regulated markets. The company's product portfolio includes biosimilars of widely used drugs such as Humira, Avastin, and Neulasta. Coherus Biosciences is committed to expanding patient access to life-changing medicines while reducing healthcare costs. The company was founded in 2010 and is headquartered in Redwood City, California.